You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

 

Online download statistics by month:

Online download statistics by month: January 2020 to February 2026

AbstractFullPdf
Jan 202012120
Feb 202048480
Mar 202037370
Apr 202020209
May 202036365
Jun 2020595917
Jul 202010106
Aug 2020323239
Sep 2020313110
Oct 2020383919
Nov 2020353520
Dec 2020333313
Jan 2021323221
Feb 2021151511
Mar 2021303022
Apr 2021161612
May 2021191919
Jun 2021727320
Jul 2021262616
Aug 202122228
Sep 2021171710
Oct 2021444426
Nov 2021323333
Dec 2021242415
Jan 2022425021
Feb 2022333313
Mar 2022687112
Apr 2022293014
May 2022273838
Jun 2022293115
Jul 202223258
Aug 2022232511
Sep 2022363723
Oct 2022404121
Nov 2022566437
Dec 202225268
Jan 2023474710
Feb 2023343619
Mar 202360627
Apr 2023282813
May 2023292912
Jun 2023404011
Jul 2023444921
Aug 2023323410
Sep 2023818316
Oct 202313113117
Nov 202310010425
Dec 202318318444
Jan 2024848481
Feb 2024555517
Mar 2024515259
Apr 2024444418
May 2024323222
Jun 2024343420
Jul 2024767612
Aug 202447509
Sep 2024373715
Oct 2024383817
Nov 2024414323
Dec 2024393918
Jan 2025414118
Feb 202524124119
Mar 2025949419
Apr 2025686819
May 2025595936
Jun 2025232412
Feb 2026110
Total308531531211